Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-10, with 109 holding rows worth $7,991,150,000.

Accession
0001053906-18-000008
Filed
2018-05-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 110 entries on the cover page, a total value of $7,991,150,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $7,991,150,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BLUE BUFFALO PET PRODS INC09531U102COM87,460,875$3,481,817,000thousands by filing date
WEIGHT WATCHERS INTL INC948626106COM29,443,300$1,876,127,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK58,274,650$499,413,000thousands by filing date
SPY78462F103SHS500,000$131,575,000thousands by filing datecall
Bank of America Corp060505104COM4,350,000$130,457,000thousands by filing datecall
GENERAL MTRS CO COM37045V100Stock3,500,000$127,190,000thousands by filing datecall
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR600,000$100,800,000thousands by filing date
International Business Machines Corporation459200101COM600,000$92,058,000thousands by filing datecall
Goldman Sachs Group,Inc.38141G104COM350,000$88,151,000thousands by filing datecall
EXXON MOBIL CORP30231G102COM1,000,000$74,610,000thousands by filing datecall
NEKTAR THERAPEUTICS640268108COM700,000$74,382,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock600,000$71,460,000thousands by filing date
Wells Fargo & Company949746101COM1,300,000$68,133,000thousands by filing datecall
CELGENE CORP151020104COM650,000$57,987,000thousands by filing datecall
Chevron Corporation166764100COM500,000$57,020,000thousands by filing datecall
Bristol-Myers Squibb Company110122108COM900,000$56,925,000thousands by filing datecall
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,250,000$48,750,000thousands by filing date
INCYTE CORP COM45337C102Stock550,000$45,832,000thousands by filing datecall
SPDR SER TR78464A870S&P BIOTECH500,000$43,865,000thousands by filing datecall
BLUEPRINT MEDICINES CORP09627Y109COM450,000$41,265,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM500,000$40,890,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,500,000$37,600,000thousands by filing date
TESARO INC881569107COM600,000$34,284,000thousands by filing date
ACCELERON PHARMA INC00434H108COM850,000$33,235,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock2,000,000$32,640,000thousands by filing date
Caterpillar Inc.149123101COM200,000$29,476,000thousands by filing datecall
BLUEBIRD BIO INC09609G100COM150,000$25,613,000thousands by filing date
INCYTE CORP COM45337C102Stock300,000$24,999,000thousands by filing date
MEDICINES CO584688105COM700,000$23,058,000thousands by filing datecall
NEKTAR THERAPEUTICS640268108COM200,000$21,252,000thousands by filing datecall
ANAPTYSBIO INC032724106COM190,000$19,775,000thousands by filing date
AVEXIS INC05366U100COM160,000$19,773,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK547,841$17,843,000thousands by filing date
FREEPORT MCMORAN INC CL B35671D857Stock1,000,000$17,570,000thousands by filing datecall
REGENERON PHARMACEUTICALS COM75886F107Stock50,000$17,218,000thousands by filing datecall
ALEXION PHARMACEUTICALS INC015351109COM150,000$16,719,000thousands by filing datecall
Vertex Pharmaceuticals Incorporated92532F100COM100,000$16,298,000thousands by filing datecall
BIOMARIN PHARMACEUTICAL INC09061G101COM200,000$16,214,000thousands by filing datecall
SAGE THERAPEUTICS INC78667J108COM100,000$16,107,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM900,000$13,536,000thousands by filing datecall
CLOVIS ONCOLOGY INC189464100COM250,000$13,200,000thousands by filing datecall
AGENUS INC00847G705COM NEW2,750,000$12,953,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR150,000$12,066,000thousands by filing date
IQIYI INC SPONSORED ADS46267X108ADR750,000$11,663,000thousands by filing date
FIBROGEN INC31572Q808COM250,000$11,550,000thousands by filing date
Accelerate Diagnostics00430H102COM500,000$11,425,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW300,000$10,782,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM200,000$9,660,000thousands by filing date
XENCOR INC98401F105COMMON STOCK300,000$8,994,000thousands by filing date
ZAFGEN INC98885E103COM1,200,000$8,940,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2300,000$8,934,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock450,000$8,861,000thousands by filing date
TESARO INC881569107COM150,000$8,571,000thousands by filing datecall
FATE THERAPEUTICS INC31189P102COM850,000$8,296,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM100,000$8,293,000thousands by filing datecall
ZOGENIX INC.98978L204Common Stock200,000$8,010,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM460,000$7,774,000thousands by filing date
REGENXBIO INC75901B107COM250,000$7,463,000thousands by filing date
VITAL THERAPIES INC92847R104COM1,000,000$6,800,000thousands by filing date
MEDICINES CO584688105COM200,000$6,588,000thousands by filing date
AC IMMUNE SAH00263105SHS600,000$6,204,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM400,000$6,120,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock150,000$6,015,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO1,900,000$5,843,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM325,000$5,275,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock45,000$5,256,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM400,000$5,196,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock550,000$5,115,000thousands by filing date
IDERA PHARMACEUTICALS INC45168K306COM2,750,000$5,060,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM350,000$4,988,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW250,000$4,963,000thousands by filing datecall
ROCKET PHARMACEUTICALS INC77313F106COM250,000$4,688,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM300,000$4,632,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM50,000$4,585,000thousands by filing datecall
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK475,000$4,527,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock150,000$4,508,000thousands by filing date
NOVAGOLD RESOURCES INC66987E206COM NEW1,000,000$4,330,000thousands by filing date
RESTORBIO INC76133L103COM450,000$4,311,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM50,000$4,089,000thousands by filing datecall
DICERNA PHARMACEUTICALS INC253031108COM425,000$4,063,000thousands by filing date
SYNLOGIC INC87166L100COM400,000$3,752,000thousands by filing date
Inflarx NvN44821101COM125,000$3,605,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock250,000$3,550,000thousands by filing date
MIRAGEN THERAPEUTICS INC60463E103COM500,000$3,505,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK216,879$3,346,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock100,000$3,266,000thousands by filing date
CLEMENTIA PHARMACEUTICALS IN185575107COM200,000$3,030,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM150,000$2,850,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM750,000$2,783,000thousands by filing date
CHIMERIX INC COM16934W106Stock500,000$2,600,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock400,000$2,320,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM150,000$2,135,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM500,000$1,910,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM90,000$1,898,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock100,000$1,875,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock300,000$1,875,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM100,000$1,870,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock150,000$1,514,000thousands by filing date
ATYR PHARMA INC002120103COM500,000$1,325,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM125,000$1,274,000thousands by filing date
TOCAGEN INC888846102COM100,000$1,185,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock25,000$1,143,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock150,000$1,125,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock150,000$1,080,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK500,000$1,050,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW256,400$897,000thousands by filing date
EDITAS MEDICINE INC28106W103COM25,000$829,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock150,000$735,000thousands by filing date
ONCOCYTE CORP68235C107COM150,000$315,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001053906-18-000008this filing2018-05-10acceptance time not in the bulk data set